Erlotinib Hydrochloride FDA Approved Drugs
TARCEVA [Erlotinib HydrochlorideC22H23N3O4ClH]
RX
- eq 100mg base (oral tablet)
eq 150mg base (oral tablet)
eq 25mg base (oral tablet)
Osi PharmsNov 18, 2004
- First-line treatment of locally advanced unresectable or metastatic pancreatic cancer, in combination with gemcitabine.
- First-line treatment of metastatic non smal-cell lung cancer (nsclc) with egfr exon 19 deletions or exon 21 (l858r) substitution mutations as detected by an fda-approved test.
- Maintenance treatment in patients with locally advanced or metastatic nsclc who have not progressed on 1st-line treatment wth platinum-based chemotherapy.
- Maintenance treatment of patients with locally advanced or metastatic nsclc whose disease has not progressed after four cycles platinum-based chemotherapy.
- Treatment of locally advanced or metastatic non small-cell lung cancer (nsclc) after failure of at least one prior chemotherapy regimen.
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.